• ABOUT US
  • MANAGEMENT TEAM
  • ACTIVITIES
  • MANAGED FUNDS
  • INVESTOR ACCESS
  • LINKS
  • INVESTMENT PROCESS
  • LATEST NEWS
  • PRESS RELEASES
  • CONTACT

February 2012
SUANFARMA BIOTECH SEGCR prepares the output to MAB of its investee PEVESA

November 2011
3P Biopharmaceuticals inspected by AEMPS for obtaining the certificate of GMP compliance

October 2011
Biotech Suanfarma has participated in a panel of judges of a biotech competition within the EmTech forum


FDA grants orphan drug designation to a new compound for acute liver failure

July 2011
Suanfarma Biotech is collaborating with Opinno in the first edition of the Opinno Biotech Competition

June 2011
Suanfarma Biotech at the Bio International Convention in Washington

May 2011
Vivia Biotech, PETHEMA and Castilla y León Healthcare, announce the first alliance in Spain about personalized medicine

March 2011
Digna Biotech begins Phase I clinical trials with Cardiotrophin I

December 2010
Pevesa signs a supply agreement with Ordesa

December 2010
Suanfarma Biotech participates in capital increase of Noscira

November 2010
Vivia Biotech receives award for the most innovative product of Castilla y Leon 2010

October 2010
Launch of GlutenTox Sticks; an accurate method to detect gluten in food

October 2010
Hector Ara, President of Suanfarma Biotech SGECR, speaker at Biospain 2010

October 2010
Gonzalo Marín, Managing Partner of Suanfarma Biotech SGECR, Advisory Board member of the 5th International Biotechnology Meeting

 

©SUANFARMA Biotech SGECR, SA 2010 | T 91 567 15 56 | suanfarmabiotech@suanfarma.com | Legal notice | Privacy policy || Web development Suanfarma Biotech en LinkedIn